2031. False-positive Serologic Results attributable to IVIG therapy

  • Hanson K
  • Gabriel N
  • Mchardy I
  • et al.
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Poster Abstracts • OFID 2018:5 (Suppl 1) • S591 PBMC, HZ cases had higher %FOXP3+CD25+(CD4+) Treg compared with controls (P = 0.08). Cases generally had lower responses to ex vivo VZV-restimulation (after subtraction of mock) compared with controls, including %perforin+(CD8+) CTL (P = 0.07) and %IL10+(CD4+) (P = 0.04) and %TGFb+(CD4+) Treg (P = 0.07). %FOXP3+CD25+(CD4+) Treg in unstimulated PBMC did not correlate with VZV-specific %perforin+(CD8+) or %IFNg+(CD4+) effector T cells, but the VZV-specific effector T cell percentages correlated with each other (r = 0.24, P = 0.05). Conclusion. Although limited by small numbers, this study showed that before development of HZ, PLWH had marginally increased number of Treg in blood and decreased VZV-specific responses. VZV-specific Treg and CTL were equally lower in cases compared with controls, suggesting that a general low VZV-specific T cell responsiveness precedes HZ in PLWH. The lack of association between circulating Treg and VZV-specific T cell responses suggests independent mechanisms of action. Disclosures.

Cite

CITATION STYLE

APA

Hanson, K. E., Gabriel, N., Mchardy, I., Hoffmann, W., Cohen, S. H., Welch, R., … Thompson, G. R. (2018). 2031. False-positive Serologic Results attributable to IVIG therapy. Open Forum Infectious Diseases, 5(suppl_1), S591–S592. https://doi.org/10.1093/ofid/ofy210.1687

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free